✦ LIBER ✦

Phase II study of sorafenib in patients with relapsed or refractory lymphoma

✍ Scribed by Anna Guidetti; Carmelo Carlo-Stella; Silvia L. Locatelli; Walter Malorni; Marina Pierdominici; Cristiana Barbati; Roberta Mortarini; Lilli Devizzi; Paola Matteucci; Alfonso Marchianò; Rodolfo Lanocita; Lucia Farina; Anna Dodero; Corrado Tarella; Massimo Di Nicola; Paolo Corradini; Andrea Anichini; Alessandro M. Gianni

Book ID: 114714717
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 341 KB
Volume: 158
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09139.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Japanese phase II study of 90Y-ibritumom

Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma

✍ Kensei Tobinai; Takashi Watanabe; Michinori Ogura; Yasuo Morishima; Tomomitsu Ho 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Phase II Study of Bendamustine in Relaps

Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma

✍ Moskowitz, A. J.; Hamlin, P. A.; Perales, M.-A.; Gerecitano, J.; Horwitz, S. M.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 110 KB

Results of a Pivotal Phase II Study of B

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

✍ Younes, Anas (author);Gopal, Ajay K. (author);Smith, Scott E. (author);Ansell, S 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 173 KB

Results of a Pivotal Phase II Study of B

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

✍ Younes, Anas (author);Gopal, Ajay K. (author);Smith, Scott E. (author);Ansell, S 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 173 KB

Phase II study of a TLR-9 agonist (1018

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma

✍ Jonathan W. Friedberg; Jennifer L. Kelly; Donna Neuberg; Derick R. Peterson; Jef 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

A phase II study of Xcellerated T cells™

A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)

✍ J.G. Gribben; N.L. Bartlett; J.J. Stephenson; M.S. Milder; R.V. Boccia; C. Redfe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB